Targeting ADAR1 lactylation activates innate immune and overcomes chemoresistance in ovarian cancer
Linlu Cui(The Affiliated Yongchuan Hospital of Chongqing Medical University), Ping Yi(The Affiliated Yongchuan Hospital of Chongqing Medical University), Fatao Luo(Sichuan University), Qihua Yi(Chongqing Three Gorges Central Hospital), Qiuying Gu(The Affiliated Yongchuan Hospital of Chongqing Medical University), T C Liu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Qingya Luo(Army Medical University), X H Luo(The Affiliated Yongchuan Hospital of Chongqing Medical University), Li Li(Sun Yat-sen University), Chunyan Tang(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Cited by 0
Related Papers
Multiple antiviral approaches of (–)-epigallocatechin-3-gallate (EGCG) against porcine reproductive and respiratory syndrome virus infection in vitro
|Antiviral Research|2018|67
Aptamer blocking S-TLR4 interaction selectively inhibits SARS-CoV-2 induced inflammation
|Signal Transduction and Targeted Therapy|2022|36
Anti-tumor effect of PD-L1-targeting antagonistic aptamer-ASO delivery system with dual inhibitory function in immunotherapy
|Cell chemical biology|2023|31
Targeting the NCOA3-SP1-TERT axis for tumor growth in hepatocellular carcinoma
|Cell Death and Disease|2020|25